The neurovascular mechanisms underpinning the local regulation of cerebral blood flow (CBF) and oxygen 8 transport remain elusive. In this study we have combined novel in vivo imaging of cortical microvascular 9 and mural cell architecture with mathematical modelling of blood flow and oxygen transport, to provide new 10 insights into CBF regulation that would be inaccessible in a conventional experimental context. Our study 11 implicates vasomotion of smooth muscle actin-covered vessels, rather than pericyte-covered capillaries, as the 12 main mechanism for modulating tissue oxygenation. We also resolve seemingly paradoxical observations in 13 the literature around reduced blood velocity in response to arteriolar constrictions and deduce the cause to 14 be propagation of constrictions to upstream penetrating arterioles. We provide support for pericytes acting 15 as signalling conduits for upstream smooth muscle activation, and erythrocyte deformation as a complemen-16 tary regulatory mechanism. Finally, we caution against the use of blood velocity as a proxy measurement 17 for flow. Our combined imaging-modelling platform complements conventional experimentation allowing 18 cerebrovascular physiology to be probed in unprecedented detail.
The relationship between vasoconstriction and haemodynamic changes is non-
In our simulations, following single vessel constriction, blood flow in penetrating and precapillary arterioles 152 decreased by 0.6 ± 1.0 and 0.6 ± 2.2%, which further decreased to −39.5 ± 13.2% when uni-directional con-153 striction cascade was introduced (see Fig 3 d , e). However, blood velocity showed changes in the opposite 154 direction, with an increase of 53.0 ± 1.6 and 17.6 ± 6.6% for penetrating and precapillary arterioles, and a 155 change of 35.9 ± 12.4 (−11.7 ± 8.0 downstream of constriction) and 22.2 ± 16.9% when uni-directional prop-156 agation was introduced. Mathematically, these opposite changes in blood flow and blood velocity observed that reductions in blood flow and velocity were mediated by decreases in blood viscosity and blood pressure, compared to pressure alone in SMA-covered vessels (see Tables S6 and S7 (a 0.08 ± 0.18% change in diameter) following optogenetic-activation and, in addition, we have shown that 176 at peak constriction, only small changes were exhibited in both blood velocity and flow (unless constriction 177 cascade is introduced). Nonetheless, it is unclear whether these small changes in flow are sufficient to impact 178 cortical oxygenation.
179
Using our flow constriction solutions, we therefore simulated changes in O 2 transport within the cortical 180 network. We observed changes in capillary PO 2 of −0.6 ± 0.08, −7.8 ± 5.9 and −9.1 ± 6.7% for constrictions 
184
This suggests that, even with minimal flow changes, significant reductions in PO 2 were found following 185 nano-scale capillary vasoconstriction, and were similar in size to those exhibited following constrictions in 186 precapillary arterioles. This effect is possible due to the combined effect of small flow reductions alongside 187 vessel haematocrit reductions (−2.9 ± 8.2 and −2.36 ± 6.58%, respectively), the latter of which plays a much 188 larger role in capillaries than in larger vessels and, in the case of micron-scale dilations, has been hypothesised 189 to be an efficient mechanism that can locally alter the distributions of RBCs in microvascular networks 40 . 60 × 60 × 60 mm 3 tissue volume centred on the constricted capillary, tissue PO 2 increased by 2.9 ± 6.6% (rather than an expected decrease; see Fig 4 d ), due to the redistribution of haematocrit to neighbouring This formed the basis for our next set of simulations, in which our baseline cortical flow solution identified 235 capillary vessels that exhibited PO 2 lower than 25 mmHg (1.7% of all capillary segments), these became 236 sites for spontaneous erythrocyte deformation (instantaneous elongation). We reduced blood viscosity in 237 these vessels by 20% to mimic the effects of erythrocyte deformation. 238 We found that spontaneous erythrocyte deformations increased blood velocity, on average, by 9.8 ± 6.2%
239
(with equivalent changes in flow). This is consistent with the peak velocity changes measured empirically 240 by Wei et al. 45 , and was accompanied by an average vessel PO 2 increase of 12.9 ± 24.3%. This provides 241 support for the hypothesis that spontaneous erythrocyte deformation is a plausible mechanism for increasing 242 vessel PO 2 . Given that we have shown that SMA-covered arterioles can dynamically alter capillary PO 2 , we 243 performed a further simulation to investigate the combined effect of arteriolar diameter changes, alongside 244 erythrocyte deformation. We induced a diameter dilation of 4.5% 45 to all SMA-exhibiting vessels (excluding 245 pial vessels) alongside erythrocyte deformation in capillaries with low-oxygen tolerance (as defined above).
246
On average, velocity and flow increased in these capillaries by 10.7±5.7%, and PO 2 increased by 18.2±31.3%. 
where N is the set of all nodes, I is the set of all interior nodes and B is the set of all boundary nodes with 408 known BCs. For all interior nodes, conservation dictates that Q 0i = 0, however, if i is a known boundary 409 node, Q 0i is the inflow (or outflow if negative). Note, at least one pressure BC needs to be assigned for a 410 unique solution. The matrix K ik represents network conductivity
where S is the set of all segments,
and
is the matrix of vessel conductances where l j , d j and µ j denote the length, diameter and effective viscosity 414 of segment j, respectively. 415 We used empirical in vivo blood viscosity laws, which prescribe the effective viscosity as a function of 
where p 0k is the target pressure at node k, τ j is the wall shear stress in segment j, τ 0j is the corresponding 428 target shear stress, k p and k τ are weighting factors associated with the pressure and shear deviations from 429 the target values, λ i is the Lagrange multiplier associated with node i and w k is the vessel length associated 430 with node k. Setting dL/dp i = 0 and combing with equation equations (1) yields the following sparse linear
where K, W, M and H, denote the matrix forms of K ik , w k , M ij and H ik , respectively. Note, W is a 433 diagonal matrix with entries w k and H ik is defined as
where c j = 4µ j /(πr 3 j ). The remaining variables p, λ, Q 0 , p 0 , τ 0 , c and are the vector forms of p k , λ k ,
where M (P ) is the oxygen consumption rate. The dependence of oxygen consumption on PO 2 is represented 444 by a Michaelis-Menten relationship
where M 0 is a uniform oxygen demand in the tissue given a non-limiting supply of oxygen and P 0 represents 446 the PO 2 at half-maximal consumption.
447
The rate of convective oxygen transport along a vessel segment is given by
where P b is the blood PO 2 level, Q is the blood flow rate, H D is the discharge haematocrit, C 0 is the con-449 centration of haemoglobin-bound oxygen in a fully saturated erythrocyte, S is the oxyhemoglobin saturation 450 and α ef f is the effective solubility of oxygen in blood. The Hill equation presents a simple description of 451 oxyhemoglobin saturation, as a consequence of oxygen binding to hemoglobin, and is given by
where n is the Hill exponent and P 50 is the PO 2 at 50% saturation. The effective solubility of oxygen in 453 blood is given by
where α p and α RBC are the solubilities in blood plasma and in RBCs, respectively. These values are similar 18 
where r v is the vessel radius and integration is performed over the circumference of the vessel, denoted by 463 the azimuthal angle θ. The blood vessel delivering the oxygen generally exceeds local PO 2 levels at the 464 interface with the surrounding tissue. Hellums 17 defined the following jump condition at the interface
where P v (s) is the average tissue P O 2 and K represents intravascular resistance to radial oxygen transport.
466
The oxygen transport model given by (8) represented as a set of discrete oxygen sources. Using superposition principles, the resulting fields from these 469 sources represent the PO 2 field in the tissue. If the rate of oxygen uptake within the tissue is prescribed, the 470 only unknowns in the problem are the strengths of both the sources and sinks. We apply this mathematical 471 model to our cortical microvascular network.
472
Modelling oxygen transport, the Green's function, G(x; x ), for a given tissue domain may be defined as 473 the PO 2 at a point x resulting from a unit point source at x , through
where D is oxygen diffusivity, α is oxygen solubility and δ 3 is the delta function in three-dimensions. Solving 
where q(x) represents the distribution of source strengths.
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